Sandoz Group AG ADR (SDZNY)
OTC
Real-time Data
01:30 PM
Day's Range
91.3052 wk Range
55.42Overview - SDZNY - Sandoz Group AG ADR
Key Statistics
Valuation
Enterprise Value
43.97B
P/E (Trailing)
‪62.21‬
P/E (Forward)
‪19.84‬
PEG Ratio
‪19.84‬
Price / Sales (TTM)
‪3.42‬
Price / Book
‪4.44‬
EV / EBITDA
‪27.94‬
Profitability
Profit Margin
‪5.53%‬
Operating Margin
‪4.25%‬
Return on Assets
‪3.06%‬
Return on Equity
‪7.24%‬
Ownership
Shares Outstanding
432.69M
Float
416.43M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.36%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪85.31‬
200-Day Avg
‪80.19‬
Dividends
Payout Ratio
‪69.44%‬
Frequency
Annual
Analyst Consensus
2 analysts
Average price target
‪$ 91.40‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SDZNY - Sandoz Group AG ADR
Peers - SDZNY - Sandoz Group AG ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
Profile Summary - SDZNY - Sandoz Group AG ADR
About
Sandoz Group AG ADR represents the American Depositary Receipts for Sandoz Group, a global leader in generic pharmaceuticals and biosimilars. As the generics division spun off from Novartis, Sandoz focuses on providing cost-effective and high-quality pharmaceutical alternatives, significantly impacting healthcare by…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
